Home
Scholarly Works
496: VALIDATION OF ANDEXANET ALFA REGIMEN FOR...
Journal article

496: VALIDATION OF ANDEXANET ALFA REGIMEN FOR REVERSAL OF ANTICOAGULATION IN PATIENTS WITH MAJOR BLEEDING

Authors

Leeds J; Xiong Y; Lovern M; Der K; Mandema J; Lu G; Curnutte J; Milling T; Crowther M; Connolly S

Journal

Critical Care Medicine, Vol. 47, No. 1, pp. 228–228

Publisher

Wolters Kluwer

Publication Date

January 1, 2019

DOI

10.1097/01.ccm.0000551248.82909.92

ISSN

0090-3493

Contact the Experts team